Science

Yüksel Ürün: A new mRNA cancer vaccine shows promise in pancreatic cancer

Yüksel Ürün/X

Feb 25, 2025, 09:18

Yüksel Ürün: A new mRNA cancer vaccine shows promise in pancreatic cancer

Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a paper by Zachary Sethna et al. published in Nature:

“A new mRNA cancer vaccine shows promise in pancreatic cancer!

In a small study, patients whose immune systems responded to the vaccine had a much lower chance of cancer coming back (RFS not reached vs. 13.4 months; p=0.007). The vaccine created long-lasting T cells that stayed active for years.

Could this be a breakthrough for cancer vaccines?”

“RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer”

Authors: Zachary Sethna, Pablo Guasp, Charlotte Reiche, Özlem Türeci, Benjamin Greenbaum, Vinod Balachandran et al.

Yüksel Ürün: A new mRNA cancer vaccine shows promise in pancreatic cancer

More posts featuring Yüksel Ürün.

Benjamin Greenbaum cancer Charlotte Reiche OncoDaily Oncology Özlem Türeci Pablo Guasp Pancreatic Cancer RNA neoantigen vaccines Vinod Balachandran Yüksel Ürün Zachary Sethna

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC